Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation

被引:0
作者
Nakashima, K
Wiese, S
Yanagisawa, M
Arakawa, H
Kimura, N
Hisatsune, T
Yoshida, K
Kishimoto, T
Sendtner, M
Taga, T
机构
[1] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cell Biol, Chiyoda Ku, Tokyo 1010062, Japan
[2] Tokyo Med & Dent Univ, Med Res Inst, Cell Fate Modulat Res Unit, Tokyo 1010062, Japan
[3] Univ Wurzburg, Dept Neurol, Clin Res Unit Neuroregenerat, D-97080 Wurzburg, Germany
[4] Univ Tokyo, Grad Sch Frontier Sci, Div Integrated Biosci, Tokyo 1138657, Japan
[5] Osaka Univ, Osaka 5650871, Japan
[6] Microbial Dis Res Inst, Dept Mol Immunol, Osaka 5650871, Japan
关键词
gp130; deficient mice; cytokine; astrocyte; motor neuron; sensory neuron;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
gp130 is a signal-transducing receptor component used in common by the interleukin-6 (IL-6) family of hematopoietic and neurotrophic cytokines, including IL-6, IL-11, leukemia-inhibitory factor, ciliary neurotrophic factor, oncostatin-M, and cardiotrophin-1. We have examined in this study a role of gp130 in the nervous system by analyzing developmental cell death of several neuronal populations and the differentiation of astrocytes in gp130-deficient mice. A significant reduction was observed in the number of sensory neurons in L5 dorsal root ganglia and motoneurons in the facial nucleus, the nucleus ambiguus, and the lumbar spinal cord in gp130 -/- mice on embryonic day 18.5. On the other hand, no significant neuronal loss was detectable on day 14.5, suggesting a physiological role of gp130 in supporting newly generated neurons during the late phase of development when naturally occurring cell death takes place. Moreover, expression of an astrocyte marker, GFAP, was severely reduced in the brain of gp130 -/- mice. Our data demonstrate that gp130 expression is essential for survival of subgroups of differentiated motor and sensory neurons and for the differentiation of major populations of astrocytes in vivo.
引用
收藏
页码:5429 / 5434
页数:6
相关论文
共 50 条
[31]   Activation of gp130 signaling in T cells drives TH17-mediated multi-organ autoimmunity [J].
Baumgartner, Francis ;
Bamopoulos, Stefanos A. ;
Faletti, Laura ;
Hsiao, Hsiang-Jung ;
Holz, Maximilian ;
Gonzalez-Menendez, Irene ;
Boldo, Llorenc ;
Horne, Arik ;
Gosavi, Sanket ;
Oezerdem, Ceren ;
Singh, Nikita ;
Liebig, Sven ;
Ramamoorthy, Senthilkumar ;
Lehmann, Malte ;
Demel, Uta ;
Kuehl, Anja A. ;
Wartewig, Tim ;
Ruland, Juergen ;
Wunderlich, Frank T. ;
Schick, Markus ;
Walther, Wolfgang ;
Rose-John, Stefan ;
Haas, Simon ;
Quintanilla-Martinez, Leticia ;
Feske, Stefan ;
Ehl, Stephan ;
Glauben, Rainer ;
Keller, Ulrich .
SCIENCE SIGNALING, 2024, 17 (824)
[32]   Bazedoxifene, a GP130 Inhibitor, Modulates EMT Signaling and Exhibits Antitumor Effects in HPV-Positive Cervical Cancer [J].
Kim, Leekyung ;
Park, Sun-Ae ;
Park, Hyemin ;
Kim, Heejung ;
Heo, Tae-Hwe .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
[33]   The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition [J].
Garbers, Christoph ;
Aparicio-Siegmund, Samadhi ;
Rose-John, Stefan .
CURRENT OPINION IN IMMUNOLOGY, 2015, 34 :75-82
[34]   Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling [J].
Wang, Yina ;
Ma, Haiyan ;
Zhao, Chongqiang ;
Liu, Tianshu ;
Yan, Dan ;
Jou, David ;
Li, Huameng ;
Zhang, Cuntai ;
Lu, Jiagao ;
Li, Chenglong ;
Lin, Jiayuh ;
Li, Sheng ;
Lin, Li .
ONCOTARGET, 2017, 8 (20) :33683-33693
[35]   Soluble gp130 prevents interleukin-6 and interleukin-11 cluster signaling but not intracellular autocrine responses [J].
Lamertz, Larissa ;
Rummel, Franziska ;
Polz, Robin ;
Baran, Paul ;
Hansen, Selina ;
Waetzig, Georg H. ;
Moll, Jens M. ;
Floss, Doreen M. ;
Scheller, Juergen .
SCIENCE SIGNALING, 2018, 11 (550)
[36]   Functional requirement of gp130-mediated signaling for growth and survival of mouse primordial germ cells in vitro and derivation of embryonic germ (EG) cells [J].
Koshimizu, U ;
Taga, T ;
Watanabe, M ;
Saito, M ;
Shirayoshi, Y ;
Kishimoto, T ;
Nakatsuji, N .
DEVELOPMENT, 1996, 122 (04) :1235-1242
[37]   Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6 [J].
Gaillard, JP ;
Mani, JC ;
Liautard, J ;
Klein, B ;
Brochier, J .
EUROPEAN CYTOKINE NETWORK, 1999, 10 (01) :43-48
[38]   Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling [J].
Pozios, Ioannis ;
Seel, Nina N. ;
Hering, Nina A. ;
Hartmann, Lisa ;
Liu, Verena ;
Camaj, Peter ;
Mueller, Mario H. ;
Lee, Lucas D. ;
Bruns, Christiane J. ;
Kreis, Martin E. ;
Seeliger, Hendrik .
CELLULAR ONCOLOGY, 2021, 44 (01) :167-177
[39]   Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling [J].
Ioannis Pozios ;
Nina N. Seel ;
Nina A. Hering ;
Lisa Hartmann ;
Verena Liu ;
Peter Camaj ;
Mario H. Müller ;
Lucas D. Lee ;
Christiane J. Bruns ;
Martin E. Kreis ;
Hendrik Seeliger .
Cellular Oncology, 2021, 44 :167-177
[40]   CD9 exacerbates pathological cardiac hypertrophy through regulating GP130/STAT3 signaling pathway [J].
Li, Yue ;
Fan, Siyuan ;
Kong, Lingyao ;
Hao, Zhenxuan ;
Zhou, Yanjun ;
Shangguan, Jiahong ;
Gao, Lu ;
Wang, Mingdan ;
Kang, Yue ;
Li, Xiangrao ;
Huang, Kun ;
Zhang, Chao ;
Liu, Zhibo .
ISCIENCE, 2023, 26 (11)